Lotte Steuten | Deputy CEO
Office of Health Economics
Bio: Prof. Lotte Steuten, PhD, is Deputy Chief Executive of the not-for-profit Office of Health Economics (OHE) and the scientific and business lead for its international research-led work program. Alongside her position at OHE, Lotte is a Visiting Honorary Professor at City University of London, an associate editor for Value in Health and served as a member of the ISPOR Board of Directors. Lotte specializes in quantitative methods for estimating the expected health and economic benefits of healthcare interventions across their lifecycle. She has applied this to various technologies and disease areas notably vaccines, antibiotics, oncology, rare diseases, ATMPs and diagnostics. She has published >100 peer–reviewed papers. Before joining OHE, Lotte worked in Seattle (US) as an Associate Professor at the University of Washington and at the Fred Hutch Cancer Research Center. She graduated cum laude with her PhD from Maastricht University (NL).
Appearances:
Day 2 - Wednesday 15th October @ 10:00
Valuing Vaccines Beyond Cost-Effectiveness
- How can we evolve beyond traditional metrics to capture the full societal value of vaccines - from pandemic prevention to economic stability?
- What would a new multidimensional framework for measuring vaccine impact look like, and how could it transform funding priorities?
- How do we bridge the gap between theoretical frameworks and real-world policy adoption - what are the barriers and opportunities?
- As the world faces new health challenges, how can expanded valuation metrics help drive better decision-making in vaccine development and implementation?
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events